Log in to save to my catalogue

Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma

Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5dd4b05d552947d19861213c0fa24315

Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma

About this item

Full title

Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma

Publisher

United States: John Wiley & Sons, Inc

Journal title

Molecular oncology, 2020-05, Vol.14 (5), p.991-1000

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

The majority of clinically diagnosed cutaneous T‐cell lymphomas (CTCL) highly express the cell‐surface markers CC chemokine receptor 4 (CCR4) and/or CD25. Recently, we have developed diphtheria toxin‐based recombinant Ontak®‐like human IL2 fusion toxin (IL2 fusion toxin) and anti‐human CCR4 immunotoxin (CCR4 IT). In this study, we first compared th...

Alternative Titles

Full title

Bispecific human IL2‐CCR4 immunotoxin targets human cutaneous T‐cell lymphoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5dd4b05d552947d19861213c0fa24315

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5dd4b05d552947d19861213c0fa24315

Other Identifiers

ISSN

1574-7891

E-ISSN

1878-0261

DOI

10.1002/1878-0261.12653

How to access this item